NASDAQ:BMRN

Biomarin Pharmaceutical Stock Forecast

etoro logo Buy BMRN
*Your capital is at risk
$55.12
-0.530 (-0.95%)
At Close: Jun 16, 2026
AI Analysis AI Analysis of BMRN AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add BMRN to Watchlist?
Some Reasons Why To Add BMRN:
  • Healthy interest coverage ratio of 19.1x
  • High gross margin of 75.9%
  • Lower volatility than the market (beta 0.24)
PDF

BioMarin Pharmaceutical Inc. stock price ended at $55.12 on Tuesday, after losing 0.95%
(Updated on Jun 16, 2026)

Hold candidate since Jun 15, 2026 Loss -0.95%

The BioMarin Pharmaceutical Inc. stock price fell by -0.95% on the last day (Tuesday, 16th Jun 2026) from $55.65 to $55.12. During the last trading day the stock fluctuated 2.23% from a day low at $54.61 to a day high of $55.83. The price has been going up and down for this period, and there has been a 3.38% gain for the last 2 weeks. Volume has increased on the last day by 37 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $79.78 million.

The stock is moving within a wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect BioMarin Pharmaceutical Inc. stock with a 90% probability to be traded between $48.69 and $57.01 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

BMRN Signals & Forecast

The BioMarin Pharmaceutical Inc. stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $56.13. On a fall, the stock will find some support from the long-term average at approximately $54.09. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, June 09, 2026, and so far it has fallen -4.82%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for BioMarin Pharmaceutical Inc. stock

BioMarin Pharmaceutical Inc. finds support from accumulated volume at $55.03 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.22 between high and low, or 2.23%. For the last week, the stock has had daily average volatility of 2.52%.

Our recommended stop-loss: $52.76 (-4.29%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 5 days ago.)

Trading Expectations (BMRN) For The Upcoming Trading Day Of Wednesday 17th

For the upcoming trading day on Wednesday, 17th we expect BioMarin Pharmaceutical Inc. to open at $55.19, and during the day (based on 14 day Average True Range), to move between $54.28 and $55.96, which gives a possible trading interval of +/-$1.69 (+/-3.11%) up or down from last closing price. If BioMarin Pharmaceutical Inc. takes out the full calculated possible swing range there will be an estimated 3.11% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $55.03 (0.16%) than the resistance at $55.46 (0.62%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is BioMarin Pharmaceutical Inc. stock A Buy?

BioMarin Pharmaceutical Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: -0.318 Hold/Accumulate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 17, 2026 - $55.19 ( 0.121%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

BMRN Performance

Trading levels for BMRN

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 56.41 2.33%
R2 55.94 1.49%
R1 55.65 0.97%
Price 55.12
S1 54.72 -0.725%
S2 54.43 -1.25%
S3 53.97 -2.09%

Accumulated Volume Support & Resistance Levels

Level Price
R3 57.29 3.94%
R2 56.05 1.69%
R1 55.46 0.617%
Price 55.12
S1 55.03 -0.163%
S2 54.10 -1.85%
S3 53.24 -3.41%

FAQ

What is the symbol for BioMarin Pharmaceutical Inc. Stock and on which exchange is it traded?
The symbol for BioMarin Pharmaceutical Inc. is BMRN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell BioMarin Pharmaceutical Inc. Stock?
BioMarin Pharmaceutical Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy BioMarin Pharmaceutical Inc. Stock?
BioMarin Pharmaceutical Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy BioMarin Pharmaceutical Inc. Stock.

What's the current price of BioMarin Pharmaceutical Inc. Stock?
As of the end of day on the Jun 16, 2026, the price of an BioMarin Pharmaceutical Inc. (BMRN) share was $55.12.

What is the 52-week high and low for BioMarin Pharmaceutical Inc. Stock?
The 52-week high for BioMarin Pharmaceutical Inc. Stock is $66.28 and the 52-week low is $49.26.

What is the market capitalization of BioMarin Pharmaceutical Inc. Stock?
As of the Jun 16, 2026, the market capitalization of BioMarin Pharmaceutical Inc. is 10.654B.

When is the next earnings date for BioMarin Pharmaceutical Inc.?
The upcoming earnings date for BioMarin Pharmaceutical Inc. is Aug 03, 2026.
Click to get the best stock tips daily for free!
ABOUT BIOMARIN PHARMACEUTICAL INC.
BioMarin Pharmaceutical
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
5.49% Jun 12
GIB
$66.69
0.225% Jun 12
EAT
$140.46
9.32% Jun 05
TPR
$140.47
6.35% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE